[ Price : $8.95]
Federal Register Notice: FDA determines that several drug products were not withdrawn from sale for reasons of safety or effective...[ Price : $8.95]
FDA grants final approval to TWi Pharmaceuticals for its ANDA for a generic version of Eisais Aricept, 23 mg to treat Alzheimers d...[ Price : $8.95]
Revive Therapeutics files an IND to FDA for REV-002 (bucillamine) for treating gout.[ Price : $8.95]
FDA approves an AstraZeneca NDA for once-daily Xigduo XR (dapagliflozin and metformin hydrochloride extended-release) for treating...[ Price : $8.95]
Attorney Kurt Karst says an Amgen complaint against Sandoz over a biosimilar version of Neupogen is demonstrating difficulties fou...[ Price : $8.95]
A Foley & Lardner online report says developers of mHealth mobile technologies must be aware of the many laws and regulations that...[ Price : $8.95]
Public comments continue to criticize an FDA draft guidance on disseminating risk information to healthcare providers for either v...[ Price : $8.95]
A citizen petition asks FDA to order extensive prescribing limitations for Cipro due to adverse events seen in post-marketing expe...